Abivax (ABVX) Treasury Shares (2024)

Abivax (ABVX) posted quarterly Treasury Shares of $131786.3 for Q3 2024, up 413.79% quarter-over-quarter from -$41998.6 in Q2 2024.

Abivax (ABVX) Treasury Shares (2024) Analysis & Trends

Abivax's Treasury Shares history runs 1 years deep, the most recent figure standing at $131786.3 for Q3 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	36.40 Mn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	5.08 Mn
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	-
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	2.72 Mn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	92,219.00
10	Abivax	9.39 Bn	9.39 Bn	-	-

Download Data